Ana Pérez

RITUXIMAB AND TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

A. Aleman, N. González-Vacarezza, G. González, 2014, International Journal of Technology Assessment in Health Care.

The Abnormal CD4+T Lymphocyte Subset Distribution and Vbeta Repertoire in New-onset Rheumatoid Arthritis Can Be Modulated by Methotrexate Treament

I. Sanz, Ana Pérez, M. Álvarez-Mon, 2019, Cells.

Overlap myositis, a distinct entity beyond primary inflammatory myositis: A retrospective analysis of a large cohort from the REMICAM registry

P. Carreira, Ana Pérez, L. Lojo, 2019, International journal of rheumatic diseases.

Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease

P. Carreira, Ana Pérez, L. Lojo, 2018, Clinical Rheumatology.

Multicenter registry on inflammatory myositis from the Rheumatology Society in Madrid, Spain: Descriptive Analysis.

P. Carreira, Ana Pérez, L. Lojo, 2017, Reumatologia clinica.

Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain

P. Carreira, Ana Pérez, L. Lojo, 2017, Rheumatology International.

Clinical Characteristics of Juvenile Idiopathic Inflammatory Myopathy and Comparison With Adult Patients

P. Carreira, Ana Pérez, E. Tomero, 2021, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis

I. Sanz, Ana Pérez, A. De La Hera, 2012, Arthritis Research & Therapy.

The number of circulating monocytes as biomarkers of the clinical response to methotrexate in untreated patients with rheumatoid arthritis

I. Sanz, Ana Pérez, A. De La Hera, 2015, Journal of Translational Medicine.

Methrotexate Treatment Inmunomodulates Abnormal Cytokine Expression by T CD4 Lymphocytes Present in DMARD-Naïve Rheumatoid Arthritis Patients

I. Sanz, Ana Pérez, M. Álvarez-Mon, 2020, International journal of molecular sciences.